Novel synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growth.
Novel synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growth.
复制标题
DOI:
10.1038/s41388-017-0076-0
复制
发表时间:
2018-05
期刊:
影响因子:
8
通讯作者:
Zhang JT
中科院分区:
文献类型:
--
作者:
Li X;Ma H;Li L;Chen Y;Sun X;Dong Z;Liu JY;Zhu W;Zhang JT
Signal transducer and activator of transcription 3 (STAT3) is constitutively activated in malignant tumors and plays important roles in multiple aspects of cancer aggressiveness. Thus, targeting STAT3 promises to be an attractive strategy for treatment of advanced metastatic tumors. Bisindolylmaleimide alkaloid (BMA) has been shown to have anti-cancer activities and was thought to suppress tumor cell growth by inhibiting protein kinase C. In this study, we show that a newly synthesized BMA analogue, BMA097, is effective in suppressing tumor cell and xenograft growth and in inducing spontaneous apoptosis. We also provide evidence that BMA097 binds directly to the SH2 domain of STAT3 and inhibits STAT3 phosphorylation and activation, leading to reduced expression of STAT3 downstream target genes. Structure activity relationship analysis revealed that the hydroxymethyl group in the 2,5-dihydropyrrole-2,5-dione prohibits STAT3-inhibitory activity of BMA analogues. Together, we conclude that the synthetic BMA analogues may be developed as anticancer drugs by targeting and binding to the SH2 domain of STAT3 and inhibiting the STAT3 signaling pathway.
登录
查看更多内容
影响因子:
4
作者:
Huang, Wei;Dong, Zizheng;Wang, Fang;Peng, Hui;Liu, Jing-Yuan;Zhang, Jian-Ting
通讯作者:
Zhang, Jian-Ting
DOI:
10.1073/pnas.0404100101
发表时间:
2004-07-20
影响因子:
11.1
作者:
Dechow, TN;Pedranzini, L;Bromberg, JF
通讯作者:
Bromberg, JF
影响因子:
11.2
作者:
Li, Yuan;Du, Hong;Yan, Cong
通讯作者:
Yan, Cong
影响因子:
4
作者:
Gartsbein, M;Alt, A;Tennenbaum, T
通讯作者:
Tennenbaum, T
影响因子:
3
作者:
Pettersen, EF;Goddard, TD;Ferrin, TE
通讯作者:
Ferrin, TE